State of IVF Marketing in India · 2026

Four-line TL;DR. IVF and fertility centre marketing in India runs on a longer decision cycle and a tighter compliance overlay (ART Act 2021, NMC Section 6, DPDP 2023, ASCI Chapter III) than most other healthcare specialties, and cost-per-qualified-lead reflects that — a wide ₹1,100–₹2,900 band depending on city tier and funnel stage. Second-opinion intent is a bigger, more valuable share of demand than most operators budget for, and tier-2/tier-3 cities are the most underserved segment ICG tracks in this category. The compliance failure that costs the most is an unsourced success-rate claim; the creative pattern that survives every regime is specific, sourced, process-first copy. A disciplined 12-week onboarding — compliance first, long-consideration landing pages second, attribution wired before spend scales — beats a fast, sloppy one in every engagement ICG has run.

Chapter 1The 2026 timeline — how IVF and fertility centres marketing has shifted this year in India

Nothing about fertility marketing in India changed overnight in 2026 — what changed is the accumulation of several smaller shifts that, taken together, moved the category meaningfully. First, digital-adoption maturity among the large multi-city fertility chains has caught up to where hospital chains and dental groups were a year or two earlier — proper GA4 event tracking, CRM-integrated lead routing, and a real compliance-review process for ad copy have become table stakes at the chain level rather than a differentiator. Second, search behaviour has shifted toward longer, more conversational queries — patients researching "IUI vs IVF success rates by age" or "what does a fertility workup actually involve" rather than short, transactional keyword searches, which has changed what "good" landing-page content looks like across the category.

Third, and this is the shift ICG has spent the most engagement time on this year, second-opinion search behaviour has become impossible to ignore in the data. A meaningful and growing share of qualified enquiries ICG tracks across fertility-centre accounts are patients who have already had at least one consultation elsewhere and are actively comparing protocols, success-rate framing, and clinic philosophy before deciding where to continue. That is a different marketing problem from acquiring a first-time patient, and most centres' 2025-era marketing programmes were not built to answer it.

Fourth, the compliance environment has tightened in enforcement attention if not in the letter of the law — the ART Act 2021 itself has not changed materially this year, but platform-level ad review (Google, Meta) and industry self-regulation (ASCI) have both grown noticeably stricter about the specific pattern of an unsourced success-rate claim, which was already the most common compliance flag ICG saw in fertility copy audits even before this tightening. Fifth, tier-2 and tier-3 city search demand has grown faster than the digitally-fluent supply serving those markets, a gap covered in full in H2 2 that ICG expects to remain the single biggest opportunity in this category through at least the next several quarters.

Chapter 2Market shape — who's spending, who's not, and the honest cohort math

The fertility-centre marketing market in India is not one homogeneous cohort — it splits cleanly into segments with meaningfully different budgets, digital-adoption levels, and competitive dynamics, and treating them as one market leads to bad benchmarking. The table below reflects the segmentation ICG uses internally when scoping a new fertility-centre engagement.

The honest cohort math worth stating plainly: the large multi-city chains, despite having the biggest budgets, are not automatically winning the category on cost-per-qualified-lead. ICG has repeatedly seen a well-run standalone centre with disciplined creative and compliance-clean copy out-perform a chain competitor's CPQL in the same city, simply because execution quality — not budget size — is the deciding variable once a baseline level of digital presence exists. The segment with the widest genuine opportunity, on the numbers ICG tracks, is not the large chains at all — it is the tier-2 and tier-3 standalone centres, covered in full in H2 3, where demand growth is outpacing supply by the widest margin in the category.

Fertility-adjacent gynaecology practices deserve a specific mention here because they are so rarely thought of as part of this market at all. A meaningful share of the eventual fertility-centre patient population first engages with a general gynaecology practice, and the query overlap between "why am I not conceiving" (gynaecology-adjacent) and "IVF centre near me" (fertility-centre-direct) is significant. Practices that build early-stage fertility-guidance content capture a real share of this pre-diagnosis research traffic, much of which eventually refers into a dedicated ART Act-registered centre — a referral pathway most fertility centres do not actively cultivate through their own marketing.

Chapter 3CPQL benchmarks across IVF and fertility centres in India Q3-2026

Cost-per-qualified-lead is the number that actually determines whether a fertility-centre marketing programme is working, and it varies more by city tier and funnel stage in this category than in almost any other specialty ICG tracks. The table below reflects ICG's Q3 2026 observation window across managed fertility-centre accounts — directional bands, not an audited market census.

ICG engagement observation, Q3 2026. Bands are directional; individual account performance varies by creative quality, compliance clean-up state, and competitive density at time of launch.

A few patterns are worth calling out beyond the raw numbers. First, the gap between top-of-funnel and decision-stage CPQL is wider in fertility marketing than in shorter-consideration specialties, which reflects the length of the decision cycle — a top-of-funnel enquiry in this category is genuinely a different, cheaper, less-qualified event than a decision-stage consultation booking, and blending the two into one CPQL number badly misrepresents account performance. Second, tier-2 decision-stage CPQL consistently lands below metro decision-stage CPQL for comparable qualification quality in every ICG account comparison run so far — a gap ICG attributes primarily to lower competitive density rather than lower search intent quality. Third, second-opinion intent occupies its own band, positioned between top-of-funnel and first-time decision-stage cost, reflecting both its lower volume and its meaningfully higher downstream conversion, covered fully in H2 4.

It is worth being explicit about what this table does not claim. It does not claim these are the only prices in the market, it does not claim ICG's sample covers every city, and it does not claim these numbers will hold steady across every quarter. It claims that this is what a reasonably representative set of ICG-managed fertility-centre accounts has actually paid, tier by tier and stage by stage, in the observation window stated.

Chapter 4Conversion benchmarks — key-event rates, cost-per-qualified-lead, downstream ratios

Cost per click is the least interesting number in fertility marketing. What actually determines whether the channel mix in H2 6 is working is the full chain — enquiry to booked consultation, booked consultation to attended consultation, and attended consultation to whatever the centre's own clinical-conversion number looks like from there. The table below combines the GA4 AI Assistant channel pattern referenced in the executive summary with ICG's broader conversion-benchmark tracking for this category.

ICG engagement observation, Q3 2026. Key-event rate is a GA4-tracked custom event; clinical-conversion figures downstream of first consult are the client's own data and are tracked but not owned by the marketing engagement.

The second-opinion → consult-attended rate outperforming first-time-patient conversion is, in ICG's view, the single most actionable finding in this section. A patient who has already had one fertility consultation elsewhere arrives at a second centre with the comparison work substantially done — they know what questions to ask, they have a diagnostic history to compare against, and they are, functionally, further along the decision journey than a first-time enquiry even though they have not yet chosen a centre. Marketing programmes that treat second-opinion traffic as a first-class segment rather than an afterthought consistently see a better return on that portion of spend, even at somewhat lower total volume.

The elevated key-event rate on the GA4 AI Assistant channel follows the same pattern ICG sees across other healthcare verticals, and the underlying mechanism is likely the same — a user who has already had a multi-turn conversational research session before clicking through arrives at the landing page with more of the qualifying work already done than a cold search click. Given how long the fertility decision cycle already runs, this pre-qualification effect matters more here than in a shorter-consideration specialty, because it can meaningfully compress the number of sessions a patient needs before booking a consultation.

Chapter 5The compliance overlay for IVF and fertility centres — which regulations govern what ad copy can and cannot say

Four regulatory and self-regulatory regimes apply to fertility-centre advertising in India, and unlike some healthcare specialties where different regimes pull in different directions, in this category they mostly reinforce the same underlying discipline: describe the service and the process, do not promise or imply an outcome, and never state a comparative or superlative claim without a citable, dated, verifiable source. Every ICG fertility-centre engagement runs a compliance pass against all four regimes below before a single line of copy or landing-page claim goes live.

Beyond the four core regimes, GA4's AI Assistant channel share and ChatGPT Ads adoption inside this vertical both interact with the compliance overlay in a specific way worth naming — a conversational ad or a conversational research thread has even less room to hedge a claim than a landing page does, which means the compliance-clean copy discipline built for search and display advertising becomes even more load-bearing as conversational channels grow their share of the mix. Centres that have already built ART Act-clean, ASCI-clean copy libraries for their existing channels have, in ICG's experience, a noticeably easier path into ChatGPT Ads than centres building compliance discipline from zero at the same time as they are learning a new channel.

Chapter 6Channel mix — where IVF and fertility centres operators are actually winning in 2026

The channel mix that works for fertility marketing looks different from a shorter-consideration healthcare specialty, primarily because the decision cycle described throughout this report demands a mix that can sustain a patient's attention across many weeks, not just win a single click.

The channel-mix mistake ICG sees most often is under-weighting SEO/AEO and organic content relative to paid media, on the logic that paid channels are more directly measurable. Given how many separate research sessions a fertility patient typically has before booking a consultation, organic and AEO-visible content is doing real work across that entire window, not just at the final click — and centres that under-invest here are, in effect, paying full paid-media price for every touchpoint in a journey that could be partly carried by compounding organic visibility instead.

Chapter 7The AIO shift — how IVF and fertility centres operators are (or aren't) showing up in AI Overview citations, ChatGPT sponsored responses, and Perplexity answers

Fertility patients research extensively before ever contacting a centre, and an increasing share of that research now happens inside AI Overviews, ChatGPT conversations, and Perplexity answers rather than through a traditional list of search results. How a fertility centre shows up — or doesn't — inside those surfaces is becoming a genuine competitive variable, not a nice-to-have.

The throughline across all four patterns above is that the same compliance discipline covered in H2 5 — specific, sourced, unembellished copy — is also the discipline that answer engines appear to favour when selecting what to cite. That is a genuinely useful alignment for this category: a centre does not have to choose between writing compliant copy and writing citable copy. The centres ICG has audited that are showing up most consistently in AI Overview citations and Perplexity answers are, without exception, also the centres with the cleanest compliance posture in their published content.

Chapter 8Attribution — GA4 AI Assistant channel share for IVF and fertility centres + backend CRM patterns

Attribution in fertility marketing has to account for a decision cycle that can stretch across eight to sixteen weeks and multiple touchpoints, which makes last-click attribution models a poor fit on their own. ICG's standard build for a fertility-centre engagement wires a conversation-completion or research-engagement event in GA4, tags every downstream lead with a source value that survives the handoff into the CRM, and — critically for this category — tags the WhatsApp follow-up channel as a distinct step in the journey rather than folding it invisibly into whichever channel captured the original enquiry.

The GA4 AI Assistant channel picks up conversational-referral traffic once the underlying event is wired, which is what makes the elevated key-event rate finding in H2 4 measurable at all. Because a fertility decision journey often includes a research phase that happens well before any lead-capture event, ICG treats last-click attribution as a conservative floor on the AI Assistant channel's real influence in this category — a pattern likely to be even more pronounced here than in shorter-consideration specialties, given how many separate sessions a fertility patient typically has before converting.

On the CRM side, the pattern ICG sees most consistently across well-run fertility-centre accounts is a lead-scoring model that treats a second-opinion enquiry as a distinct, higher-priority lead type from the moment it enters the CRM — not because it is higher volume, but because the downstream consult-attended rate is meaningfully better, as established in H2 4, and a centre's sales or patient-coordination team should be prioritising follow-up accordingly rather than treating every enquiry identically.

Chapter 9Creative — the copy patterns that survive both auction and regulator in IVF and fertility centres

Good creative for fertility-centre marketing in India has to clear the same two bars as every other healthcare specialty ICG works in — relevance for the auction, and compliance for the regulator — but the specific patterns that satisfy both bars look different in this category because of how sensitive the subject matter is and how long the decision window runs.

The broader shift these patterns describe: fertility creative rewards restraint even more than most other healthcare specialties. Urgency-driven, outcome-promising copy both under-performs on genuine engagement in ICG's tracked accounts and draws the sharpest compliance scrutiny of anything in this category. Copy that reads like a knowledgeable, honest clinician explaining what the process actually involves — with named specialists and specific, sourced facts rather than percentages and promises — consistently wins more of both the auction and the trust.

Chapter 10Landing-page discipline for IVF and fertility centres — mobile-first, schema-clean, cite-friendly

A fertility-centre landing page has a harder job than most healthcare landing pages, because it is rarely the only page the patient will visit before deciding, and it needs to earn a return visit as much as it needs to convert on the first one. Mobile-first is non-negotiable — the majority of fertility research sessions ICG tracks happen on mobile, often during moments of privacy rather than at a desk. Schema-clean structure (FAQ markup, Article/MedicalWebPage markup where appropriate, clear author and specialist bylines) matters for the same reason covered in H2 7 — it is the same signal set that improves both compliance clarity and AI Overview citability.

The content structure ICG's best-performing fertility landing pages share: an honest explanation of what a first consultation actually involves, a clear diagnostic-workup outline, protocol-approach description rather than outcome promise, named-specialist credibility signals, and a second-opinion-specific pathway distinct from the first-time-enquiry pathway. Pages that lead with a promotional headline and a single generic contact form — the pattern most common in the tier-2/tier-3 segment covered in H2 2 — consistently underperform this structure, even when paid-media spend behind them is comparable.

Chapter 11What IVF and fertility centres operators consistently get wrong in 2026

The mistakes below are not rare or obscure — they are the patterns ICG sees repeatedly across new fertility-centre audits, and each one has a measurable cost attached to it in the data ICG tracks.

None of these mistakes are difficult to fix once identified — they are almost all structural rather than creative, which is actually good news for an operator reading this report. The fix is usually a matter of restructuring the funnel and the copy library around the real shape of the fertility decision journey, not a matter of spending more.

Chapter 12What the top decile is doing differently

Across every fertility-centre engagement ICG has run, a consistent pattern separates the accounts that land at the top of the CPQL and conversion distribution from the ones that sit in the middle.

What is notable about this list is that none of it is about outspending the competition. Every one of these practices is available to a standalone single-city centre as much as it is to a multi-city chain — which is consistent with the finding in H2 2 that execution quality, not budget size, is the deciding variable in this category once a baseline digital presence exists.

Chapter 13Case snapshots — five hypothetical scenarios anchored in IVF and fertility centres

The snapshots below are composite, hypothetical patterns representative of the kinds of engagements ICG has run in this category — not disclosures of any specific named client's data. They are included to make the report's findings concrete rather than abstract.

Chapter 14Budget allocation for IVF and fertility centres in 2026 — how the winners are splitting media

The question ICG gets most often from fertility-centre operators is not "does digital marketing work for this category" — the benchmarks above answer that — but "how should the budget actually be split." The allocation below reflects ICG's current guidance for a well-run, blended fertility-centre media budget in late 2026.

The higher SEO/AEO weighting relative to other healthcare specialties is deliberate — given the long consideration window covered throughout this report, compounding organic and AI-answer-engine visibility is doing real work across many research sessions per patient, not just capturing the final click. The conservative ChatGPT Ads allocation reflects where the category actually is in its adoption curve, covered in H2 7 — not a judgement that the channel is a poor fit, but a recognition that most fertility centres have not yet built the compliance-clean copy library the channel requires before spend should scale meaningfully.

Chapter 15Predictions for Q4-2026 and 2027 in IVF and fertility centres

Five things ICG expects to see move over the next two to four quarters, offered as predictions rather than certainties:

• Tier-2 and tier-3 fertility search demand continues to outpace supply through Q4 2026 and into 2027 — the CPQL gap between metro and tier-2 markets described in H2 3 is likely to compress as more operators build genuine tier-2 presence, but ICG expects the window described in H2 2 to stay open through at least the next two to three quarters.
• Second-opinion intent grows as a share of total fertility search volume — as more patients treat a first fertility consultation as one data point rather than a final answer, the comparison-stage creative track described in H2 9 becomes more central to a well-run account, not a niche add-on.
• ChatGPT Ads adoption inside this vertical accelerates once more centres build compliance-clean sponsored-response copy libraries — the structural fit described in H2 7 is strong; the adoption gap is a copy-and-compliance gap, not a demand gap, and ICG expects that gap to close over the next several quarters.
• Compliance scrutiny on unsourced success-rate claims increases — this is already the most common flag ICG sees in fertility copy audits, and as ad volume in the category grows, expect tighter platform-level and regulatory-level enforcement specifically around this claim type.
• AIO and answer-engine citation share becomes a genuine competitive differentiator — the pattern in H2 8, where compliance-clean, source-attributed content is favoured by answer engines, will matter more as a larger share of early-stage fertility research happens inside conversational AI products rather than traditional search.

None of these predictions should change a fertility-centre operator's decision to invest in a properly structured marketing programme now — if anything, the tightening compliance scrutiny and the still-open tier-2/tier-3 window are both reasons to move earlier rather than later, while the conditions described throughout this report still hold.

Chapter 16The 12-week onboarding playbook for a IVF and fertility centres operator starting today

Every ICG fertility-centre engagement follows some version of the same 12-week structure, adjusted for the specific findings in this report — the ART Act compliance gate happens first, not last, and the landing-page rebuild is built explicitly for a long-consideration journey rather than a same-week-decision funnel.

Retainers for this engagement structure start from ₹20,000/month, custom-scoped per engagement based on city footprint, competitive density, and whether the centre is standalone or part of a multi-city group.

Chapter 17About the data + methodology

This report draws on three kinds of information, and we have tried to label which is which throughout rather than blur them together. First, ICG engagement data — actual CPQL, conversion, and attendance figures observed across managed fertility-centre accounts during the observation window stated. These are the numbers behind the CPQL and conversion tables in H2 3 and H2 4, and they are directional bands drawn from ICG's own portfolio — not a market census. Second, industry observation — broader statements about category trends, adoption pace, and platform direction informed by what ICG sees across the wider healthcare marketing landscape but not tied to a specific measured account. Third, honest projection — the predictions in H2 15, offered explicitly as forecasts rather than facts.

We have deliberately avoided fabricating precision this report cannot support. No specific client is named anywhere in this report, and every case snapshot in H2 13 is a composite, hypothetical pattern rather than a disclosure of a single named client's data. Where a number appears as a range, that range reflects genuine variance in what ICG has observed, not a rounding convenience. Where a claim is described as an "ICG observation," an "engagement pattern," or "portfolio-observed" rather than a statistic, that phrasing is intentional and should be read as exactly what it says — not as verified, audited market data. This report will be revised as ICG's fertility-centre portfolio grows — treat the 2026 vintage as a first, honest snapshot, not a finished body of research.

Chapter 18About Ichelon Consulting Group

Ichelon Consulting Group (ICG) is an AI-first healthcare marketing agency built specifically for clinics, hospitals, diagnostics chains, fertility centres, aesthetic and dermatology practices, pharma brands, medical device companies, and Ayurvedic and wellness centres across India. ICG runs Google Ads, Meta Ads, ChatGPT Ads, SEO/AEO, GBP, YouTube, and WhatsApp-based recall automation as an integrated operating system rather than a set of siloed vendor relationships, with compliance discipline against the ART Act 2021, NMC Section 6, DPDP 2023, and ASCI Chapter III built into every campaign from the first line of copy — a discipline this report treats as central to the fertility category specifically, not an afterthought layered on at the end.

ICG's three Co-Founders — Abhash, Deep, and Rohit — lead a team built entirely around India's healthcare marketing category, with no adjacent-industry distraction. If you run a fertility centre, a fertility chain, or a fertility-adjacent gynaecology practice and want a partner who understands both the ART Act compliance overlay and the long-consideration marketing mechanics this category actually requires, ICG is happy to have that conversation directly — no gated form, no lengthy sales process, just a WhatsApp message or a discovery call.

Backed by App\Support\NamedExperts::get(). --}}

Frequently asked — about this report

What does a fertility centre in India typically pay per qualified lead in 2026?

ICG-observed cost-per-qualified-lead currently sits in a wide ₹1,100–₹2,900 band depending on city tier and funnel stage — metro decision-stage leads sit at the top of that range, tier-2 leads sit meaningfully lower for comparable qualification quality. See H2 3 for the full band table.

Why is IVF marketing more expensive per lead than dental or dermatology marketing?

The decision cycle in fertility care routinely runs eight to sixteen weeks from first search to first consult, compared to a much shorter window in most other healthcare specialties. A longer consideration window generally means a higher cost per qualified lead but also a more durable, more valuable pipeline once it is properly nurtured. See H2 4.

What is the ART Act 2021 and how does it affect fertility marketing copy?

The Assisted Reproductive Technology Act 2021 is the primary regulation governing fertility-centre advertising in India — no success-rate claims without registry-verifiable data, and strict boundaries around sex-selection-adjacent and surrogacy-adjacent language. It is the first compliance gate every ICG fertility engagement runs before any copy goes live. See H2 5.

Is second-opinion traffic a meaningful part of fertility centre demand in India?

Yes — a meaningful share of qualified leads ICG tracks in this category are patients already mid-cycle elsewhere, actively comparing protocols before committing to a second consultation. This segment tends to convert to a booked consult more reliably than first-time-patient traffic, though at somewhat lower volume. See H2 4 and H2 9.

How does GA4's AI Assistant channel perform for fertility centre marketing?

ICG-tracked fertility properties show an elevated key-event rate on the AI Assistant channel compared to organic and direct traffic on the same properties, consistent with the pattern across healthcare verticals — a conversational research thread tends to pre-qualify a fertility enquiry more thoroughly than a single search query. See H2 8.

Are fertility centres adopting ChatGPT Ads in India yet?

Adoption is still early relative to dental, dermatology, and hair transplant, primarily because most fertility centres have not yet built compliance-clean sponsored-response copy libraries — not because the format is a poor fit. The category's long, comparison-heavy research pattern is structurally well suited to conversational advertising. See H2 7.

Which cities have the biggest opportunity for fertility centre marketing right now?

ICG's tracked data shows tier-2 and tier-3 city fertility search demand growing faster than metro demand, without a matching growth in digitally-fluent local supply — a widening service gap that rewards operators willing to build a genuine local presence. See H2 2.

What compliance regimes apply to IVF advertising in India, besides the ART Act?

NMC Section 6 (outcome-guarantee and comparative-claim restrictions), DPDP Act 2023 (sensitive personal-data handling for fertility enquiries), and ASCI Chapter III (unsubstantiated efficacy and superlative-claim restrictions) all apply alongside the ART Act, and in this category they largely reinforce rather than conflict with each other. See H2 5.

What is the most common compliance mistake fertility centres make in their marketing?

Leading with an unsourced success-rate percentage — the single most common flag ICG sees in fertility copy audits. It draws attention in the short run and regulatory or platform risk in the medium run. See H2 11.

How long does the average fertility patient take to decide on a centre?

ICG's engagement pattern shows a typical decision cycle of eight to sixteen weeks from first search to first consultation — materially longer than most other healthcare specialties, which shapes everything from landing-page structure to follow-up cadence. See H2 1 and H2 10.

What channels perform best for fertility centre marketing in India?

Google Ads remains the primary decision-stage and second-opinion channel; Meta Ads drives top-of-funnel awareness and partner/family reach; SEO/AEO carries outsized weight given the long consideration window; WhatsApp is central to follow-up given how long the decision cycle runs. See H2 6 and H2 14.

How should a fertility centre structure its landing pages differently from other healthcare specialties?

Mobile-first, schema-clean, and built to explain process and protocol rather than push an immediate booking — a fertility enquiry rarely converts on the first visit given the length of the decision cycle, so the page needs to earn a return visit as much as a first click. See H2 10.

Do second-opinion patients need different marketing creative from first-time patients?

Yes. ICG maintains these as separate creative tracks — second-opinion copy addresses a patient who already has a protocol and diagnostic history to compare against, while first-time-patient copy needs to establish the basics of what a fertility workup involves. Blending the two into one message underserves both. See H2 9.

What are the top mistakes IVF and fertility centre operators make in 2026?

Leading with unsourced success-rate claims, treating the funnel like a same-week-decision category, blending first-time and second-opinion creative into one message, under-investing in tier-2/tier-3 presence, and failing to track WhatsApp follow-up attribution. See H2 11 for the full list.

What does the top decile of fertility centre marketers do differently?

They separate creative and landing tracks by patient stage, build compliance review into the content calendar rather than bolting it on after, invest in genuine tier-2 presence rather than copy-pasted metro pages, lean on named specialists and process transparency, and run a WhatsApp-anchored nurture sequence matched to the real decision window. See H2 12.

How should a fertility centre split its 2026 marketing budget across channels?

ICG's current guidance: 35-45% Google Ads, 20-30% Meta Ads, 20-25% SEO/AEO retainer, 5-15% ChatGPT Ads and emerging conversational channels, with WhatsApp/recall automation budgeted as an operational retainer rather than a media line. See H2 14.

What does the 12-week fertility-centre marketing onboarding playbook cover?

Compliance review against the ART Act, NMC, DPDP, and ASCI regimes; landing-page rebuild for a long-consideration journey; a narrow-scope pilot with attribution wired before spend scales; a first optimisation pass; a scale decision benchmarked against the CPQL bands in this report; and full integration into standing reporting. See H2 16.

Is this report based on real client data or industry estimates?

Both, and we label which is which throughout. Specific benchmark bands (CPQL, conversion rates) are drawn from ICG engagement data across managed fertility-centre accounts; broader statements about category trends are industry observation, and forward-looking statements are explicitly labelled as predictions. See H2 17 for the full methodology note.

How can a fertility centre start working with ICG?

WhatsApp ICG directly with your city, current monthly media spend, and whether you are a standalone centre or part of a chain for a directional read, or book a discovery call to walk through the 12-week playbook against your specific situation. Retainers start from ₹20,000/month, custom-scoped per engagement.